Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
- DOI
- 10.1016/j.ophtha.2013.09.048
- Published
- 2013-12-17
- Container
- Ophthalmology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ophtha.2013.09.048,
title = {Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.},
author = {Levy-Clarke G and Jabs DA and Read RW and Rosenbaum JT and Vitale A and Van Gelder RN.},
year = {2014},
journal = {Ophthalmology},
doi = {10.1016/j.ophtha.2013.09.048},
url = {https://doi.org/10.1016/j.ophtha.2013.09.048}
}RIS
TY - JOUR TI - Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. AU - Levy-Clarke G AU - Jabs DA AU - Read RW AU - Rosenbaum JT AU - Vitale A AU - Van Gelder RN. PY - 2014 JO - Ophthalmology DO - 10.1016/j.ophtha.2013.09.048 UR - https://doi.org/10.1016/j.ophtha.2013.09.048 ER -
APA
G, L., DA, J., RW, R., JT, R., A, V., & RN., V. G. (2014). Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.. Ophthalmology. https://doi.org/10.1016/j.ophtha.2013.09.048
Source records
- europe-pmc · retrieved 2026-09-26T17:56:29.325Z